- cafead   Mar 14, 2024 at 11:42: AM
via Blue chip international investors have weighed into a £25.2 million fundraising round to back significant progress for Cambridge clinical stage biotech Mission Therapeutics. The company is developing first-in-class therapeutics that enhance mitophagy to promote cell/organ health.
article source
article source